Global Financial Private Client, LLC Gilead Sciences, Inc. Transaction History
Global Financial Private Client, LLC
- $267 Billion
- Q4 2024
A detailed history of Global Financial Private Client, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 6,068 shares of GILD stock, worth $557,285. This represents 0.21% of its overall portfolio holdings.
Number of Shares
6,068
Previous 459
1222.0%
Holding current value
$557,285
Previous $38.5 Million
1356.49%
% of portfolio
0.21%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
1,941Shares Held
989MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.6 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.03 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.68 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.53 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $115B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...